ET-008

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameET-008
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor H inhibitorsTumor necrosis factor receptor superfamily member 5 inhibitorsImmunomodulators +[4] 
TargetsComplement factor DComplement factor HTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocrine Technology LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocrine Technology LLC
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A